PDF herunterladen
Exp Clin Endocrinol Diabetes 2018; 126(04): 222-228
DOI: 10.1055/s-0043-119751
Article

The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Authors

  • Golara Mirmasoumi

    1   Department of Biochemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, I.R. Iran

  • Mohammad Fazilati

    1   Department of Biochemistry, Shahreza Branch, Islamic Azad University, Shahreza, Isfahan, I.R. Iran
    2   Department of Biology, Pyamenoor University, Tehran, Iran

  • Fatemeh Foroozanfard

    3   Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran

  • Zahra Vahedpoor

    3   Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran

  • Samaneh Mahmoodi

    3   Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran

  • Mohsen Taghizadeh

    4   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • Nazanin Kazemi Esfeh

    4   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • Maryam Mohseni

    4   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran

  • Hassan Karbassizadeh

    5   Barij Medicinal Plants Research Center, Kashan, I.R. Iran

  • Zatollah Asemi

    4   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran
Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints
Preview

Einführung zu diesem Artikel:

Note of Concern: The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled TrialExp Clin Endocrinol Diabetes 2018; 126(04): 222-228
DOI: 10.1055/a-1736-9017

Abstract

Objective This study was conducted to evaluate the effects of flaxseed oil omega-3 fatty acids supplementation on metabolic status of patients with polycystic ovary syndrome (PCOS).

Methods This randomized double-blind, placebo-controlled trial was conducted on 60 women with PCOS according to the Rotterdam criteria aged 18–40 years old. Participants were randomly assigned into two groups to receive either 1,000 mg flaxseed oil omega-3 fatty acids (n=30) or placebo (n=30) twice a day for 12 weeks. Metabolic, endocrine, inflammatory factors were quantified at baseline and after the 12-week intervention.

Results After the 12-week intervention, compared to the placebo, flaxseed oil omega-3 supplementation significantly decreased insulin values (−2.6±7.7 vs.+1.3±3.9 µIU/mL, P=0.01), homeostasis model of assessment-estimated insulin resistance (−0.7±1.7 vs.+0.3±0.9, P=0.01), mF-G scores (−1.2±1.7 vs. -0.1±0.4, P=0.001), and increased quantitative insulin sensitivity check index (+0.01±0.02 vs. −0.01±0.02, P=0.01). In addition, supplementation with flaxseed oil omega-3 resulted in significant decreases in serum triglycerides (−5.1±20.9 vs.+9.7±26.1 mg/dL, P=0.01), VLDL-cholesterol (−1.0±4.2 vs.+1.9±5.2 mg/dL, P=0.01) and high-sensitivity C-reactive protein (hs-CRP) (−1.6±3.1 vs.+0.2±1.5 mg/L, P=0.004) compared to the placebo. We did not see any significant effect of flaxseed oil omega-3 supplementation on hormonal and other lipid profiles, and plasma nitric oxide levels.

Conclusions Overall, flaxseed oil omega-3 supplementation for 12 weeks in women with PCOS had beneficial effects on insulin metabolism, mF-G scores, serum triglycerides, VLDL-cholesterol and hs-CRP levels, but did not affect hormonal and other lipid profiles, and plasma nitric oxide levels.

Key words

Flaxseed oil supplementation - metabolic status - polycystic ovary syndrome


Publikationsverlauf

Eingereicht: 08. Juni 2017
Eingereicht: 12. September 2017

Angenommen: 14. September 2017

Artikel online veröffentlicht:
08. November 2017

© 2018. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Trikudanathan S. Polycystic ovarian syndrome. Med Clin North Am 2015; 99: 221-235
    Suche in Google Scholar
  • 2 Vagi SJ, Azziz-Baumgartner E, Sjodin A. et al. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study. BMC Endocr Disord 2014; 14: 86
    Suche in Google Scholar
  • 3 Pourghassem Gargari B, Houjeghani S, Farzadi L. et al. Relationship between serum leptin, ghrelin and dietary macronutrients in women with polycystic ovary syndrome. Int J Fertil Steril 2015; 9: 313-321
    Suche in Google Scholar
  • 4 Macut D, Bjekic-Macut J, Savic-Radojevic A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res 2013; 40: 51-63
    Suche in Google Scholar
  • 5 Schmidt J, Weijdegard B, Mikkelsen AL. et al. Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women. Mol Hum Reprod 2014; 20: 49-58
    Suche in Google Scholar
  • 6 Jalilian A, Kiani F, Sayehmiri F. et al. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis. Iran J Reprod Med 2015; 13: 591-604
    Suche in Google Scholar
  • 7 Rafraf M, Mohammadi E, Asghari-Jafarabadi M. et al. Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. J Am Coll Nutr 2012; 31: 361-368
    Suche in Google Scholar
  • 8 Prasad K. Flaxseed and cardiovascular health. J Cardiovasc Pharmacol 2009; 54: 369-377
    Suche in Google Scholar
  • 9 Nasri K, Hantoushzadeh S, Aghadavod E. et al. The effects of omega-3 fatty acids supplementation on gene expression involved in the insulin and lipid signaling pathway in patients with polycystic ovary syndrome. Horm Metab Res 2017; 49: 446-451
    Suche in Google Scholar
  • 10 Cunnane SC, Hamadeh MJ, Liede AC. et al. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995; 61: 62-68
    Suche in Google Scholar
  • 11 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
    Suche in Google Scholar
  • 12 Oner G, Muderris II. Efficacy of omega-3 in the treatment of polycystic ovary syndrome. J Obstet Gynaecol 2013; 33: 289-291
    Suche in Google Scholar
  • 13 Fulghesu AM, Romualdi D, Di Florio C. et al. Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. Hum Reprod 2012; 27: 3057-3066
    Suche in Google Scholar
  • 14 Hatch R, Rosenfield RL, Kim MH. et al. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815-830
    Suche in Google Scholar
  • 15 Pisprasert V, Ingram KH, Lopez-Davila MF. et al. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013; 36: 845-853
    Suche in Google Scholar
  • 16 Tatsch E, Bochi GV, Pereira Rda S. et al. de Campos MM, et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 2011; 44: 348-350
    Suche in Google Scholar
  • 17 Zheng SH, Li XL. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS. Gynecol Endocrinol 2016; 32: 177-183
    Suche in Google Scholar
  • 18 Hyderali BN, Mala K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2015; 191: 15-22
    Suche in Google Scholar
  • 19 Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis. Fertil Steril 2011; 95: 1048-1058 e1-2
    Suche in Google Scholar
  • 20 Mohammadi E, Rafraf M, Farzadi L. et al. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 2012; 21: 511-518
    Suche in Google Scholar
  • 21 Navas-Carretero S, Perez-Granados AM, Schoppen S. et al. An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women. Br J Nutr 2009; 102: 546-553
    Suche in Google Scholar
  • 22 Eritsland J, Seljeflot I, Abdelnoor M. et al. Long-term effects of n-3 fatty acids on serum lipids and glycaemic control. Scand J Clin Lab Invest 1994; 54: 273-280
    Suche in Google Scholar
  • 23 Rasic-Milutinovic Z, Perunicic G, Pljesa S. et al. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail 2007; 29: 321-329
    Suche in Google Scholar
  • 24 Hutchins AM, Brown BD, Cunnane SC. et al. Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res 2013; 33: 367-375
    Suche in Google Scholar
  • 25 Sadeghi A, Djafarian K, Mohammadi H. et al. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2017; 11: 157-162
    Suche in Google Scholar
  • 26 Legro RS. Polycystic ovary syndrome and cardiovascular disease: A premature association?. Endocr Rev 2003; 24: 302-312
    Suche in Google Scholar
  • 27 Cassar S, Teede HJ, Harrison CL. et al. Biomarkers and insulin sensitivity in women with PCOS: Characteristics and predictive capacity. Clin Endocrinol (Oxf) 2015; 83: 50-58
    Suche in Google Scholar
  • 28 Bellenger J, Bellenger S, Bataille A. et al. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: Inflammatory pathway inhibition. Diabetes 2011; 60: 1090-1099
    Suche in Google Scholar
  • 29 Cussons AJ, Watts GF, Mori TA. et al. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 2009; 94: 3842-3828
    Suche in Google Scholar
  • 30 Vargas ML, Almario RU, Buchan W. et al. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism 2011; 60: 1711-1718
    Suche in Google Scholar
  • 31 Oh R. Practical applications of fish oil (Omega-3 fatty acids) in primary care. J Am Board Fam Pract 2005; 18: 28-36
    Suche in Google Scholar
  • 32 Woodman RJ, Mori TA, Burke V. et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002; 76: 1007-1015
    Suche in Google Scholar
  • 33 Fakhrzadeh H, Ghaderpanahi M, Sharifi F. et al. The effects of low dose n-3 fatty acids on serum lipid profiles and insulin resistance of the elderly: A randomized controlled clinical trial. Int J Vitam Nutr Res 2010; 80: 107-116
    Suche in Google Scholar
  • 34 Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008; 19: 242-247
    Suche in Google Scholar
  • 35 Qi K, Fan C, Jiang J. et al. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin Nutr 2008; 27: 424-430
    Suche in Google Scholar
  • 36 Tsitouras PD, Gucciardo F, Salbe AD. et al. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 2008; 40: 199-205
    Suche in Google Scholar
  • 37 Li H, Ruan XZ, Powis SH. et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005; 67: 867-874
    Suche in Google Scholar
  • 38 Rossi A, Kapahi P, Natoli G. et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000; 403: 103-108
    Suche in Google Scholar
  • 39 Wu D, Han SN, Meydani M. et al. Effect of concomitant consumption of fish oil and vitamin E on production of inflammatory cytokines in healthy elderly humans. Ann N Y Acad Sci 2004; 1031: 422-424
    Suche in Google Scholar